Delivery Order SPE2DR25D3102-SPE2DR26F2P5S
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $2,018.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, a critical care medication, with an ultimate completion date of August 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
- The Defense Logistics Agency awarded a $3,595.56 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this pharmaceutical supply delivery. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,397.66 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract, with no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Talvey 40 mg/ml vials valued at $13,518.20, with completion scheduled for December 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on October 23, 2025, with a ceiling value of $1,823.55 and firm fixed pricing. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by October 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $1,760.88 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for Valtoco 10 mg nasal sprays, with completion scheduled for November 17, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,415.57 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of December 12, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,507.97 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on July 15, 2025, with completion scheduled for July 16, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The award was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,581.07 to AmerisourceBergen Drug Corp for Vanflyta 17.7 mg tablets (28-count package) on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,743.34 for Valtoco 10 mg nasal sprays, a medication used in emergency seizure management. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The delivery order was...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2P5SDelivery Order
The Defense Logistics Agency awarded a $1,400.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtya 1 mg–50 mcg tablets (28 count) on December 12, 2025, with an ultimate completion date of December 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen leverages its prime IDC vehicle to supply a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. This particular delivery order for Valtya tablets falls within the company's broader portfolio of pharmaceutical products delivered through the DLA Medical Supply Chain, which encompasses specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. The firm fixed-price structure and delivery order mechanism reflect the established pricing and terms negotiated under the underlying IDC, enabling efficient procurement of pharmaceutical commodities for federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/11/25 |